SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Pieris Pharmaceuticals, Inc. – PIRS

Group 1 - Monteverde & Associates PC is investigating Pieris Pharmaceuticals, Inc. regarding its proposed merger with Palvella Therapeutics, Inc. [1] - Under the merger agreement, Pieris shareholders are expected to own approximately 18% of the combined company [1] - Monteverde & Associates PC has been recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report [1] Group 2 - The firm has a successful track record in recovering money for shareholders and litigating class actions [2] - Monteverde & Associates PC operates from the Empire State Building in New York City [2] - The firm emphasizes the importance of legal representation and encourages potential clients to inquire about their experience and success rates [2]